Free preview

Acute Myelogenous Leukemia (AML)

Overview and clinical definition are open. Full Step 1 details unlock with a plan.

For the why behind the fact

Use this page to connect what you are memorizing.

Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.

Overview


Plain-Language Overview

Acute Myelogenous Leukemia (AML) is a type of cancer that affects the blood and bone marrow, where blood cells are made. It causes the rapid growth of abnormal white blood cells that crowd out normal cells, leading to problems like anemia, infections, and easy bleeding. This condition mainly impacts the body's ability to fight infections and carry oxygen. Symptoms often include fatigue, frequent infections, and bruising or bleeding easily. AML can develop quickly and requires prompt medical attention to manage the disease and its effects on overall health.

Clinical Definition

Acute myeloid (myelogenous) leukemia, AML, is a clonal malignancy of hematopoietic progenitors with impaired myeloid differentiation and accumulation of abnormal blasts or related immature cells. Suppression of normal hematopoiesis produces anemia, thrombocytopenia and impaired infection defense; the total WBC may be high, normal or low. Classification integrates morphology, immunophenotype and genetics, including RUNX1::RUNX1T1, CBFB::MYH11, NPM1 and FLT3 alterations. APL with PML::RARA is an AML subtype with a distinct differentiation block and dangerous coagulopathy. AML is most common in older adults but occurs at any age.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses